- Recommendation ID
- NG14/02
- Question
Safety, prognostic and predictive biomarkers: Can biomarkers be used for risk stratification and treatment planning for people with melanoma?
- Any explanatory notes
(if applicable) For a short explanation of why the committee made the recommendation for research, see the rationale section on BRAF analysis of melanoma tissue samples.
Full details of the evidence and the committee's discussion are in evidence review A: genetic testing for melanoma.
Source guidance details
- Comes from guidance
- Melanoma: assessment and management
- Number
- NG14
- Date issued
- July 2015
Other details
| Is this a recommendation for the use of a technology only in the context of research? | No |
| Is it a recommendation that suggests collection of data or the establishment of a register? | No |
| Last Reviewed | 31/07/2022 |